NCT05712941 2023-11-03Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial CancerEQRx International, Inc.Phase 3 Withdrawn